A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions

To evaluate the bioequivalence and safety of AJU-B718 and B718R in Healthy Adults.

Inclusion Criteria: * Adults aged 19 to less than 65 years at screening. * Healthy adults without clinically significant congenital or chronic diseases. * Considered eligible based on screening test results. * BMI 18 to 30 kg/m², with body weight ≥50 kg for males and ≥45 kg for females. * Provided written informed consent. * Willing to comply with the specified contraception and reproductive restrictions. Exclusion Criteria: * Use of prohibited or potentially interfering medications within the specified period prior to the first administration. * Excessive alcohol consumption within 1 month prior to the first administration. * Participation in another clinical trial involving administration of an investigational product within 6 months prior to the first administration. * Blood donation within the specified period prior to the first administration. * History of gastrointestinal surgery that may affect drug absorption. * Clinically significant bleeding disorders or other medical conditions that may affect study participation. * History of clinically significant psychiatric disorders. * Considered unsuitable for study participation by the Investigator or delegated physician. * Pregnancy, suspected pregnancy, or breastfeeding in female participants.